Tag Archives: TRIUMF

From the quantum to the cosmos; an event at Vancouver’s (Canada) Science World

ARPICO (Society of Italian Researchers & Professionals in Western Canada) sent out an April 9, 2014 announcement,

FROM THE QUANTUM TO THE COSMOS

May 7 [2014] “Unveiling the Universe” lecture registration now open:

Join Science World and TRIUMF on Wednesday, May 7, at Science World at TELUS World of Science in welcoming Professor Edward “Rocky” Kolb, the Arthur Holly Compton Distinguished Service Professor of Astronomy and Astrophysics at the University of Chicago, for his lecture on how the laws of quantum physics at the tiniest distances relate to structures in the universe at the largest scales. He also will highlight recent spectacular results into the nature of the Big Bang from the orbiting Planck satellite and the South Pole-based BICEP2 telescope.

Doors open at 6:15pm and lecture starts at 7pm. It will be followed by an audience Q&A session.

Tickets are free but registration is required. Details on the registration page (link below)
See http://www.eventbrite.ca/o/unveiling-the-universe-lecture-series-2882137721?s=23658359 for more information.

You can go here to the Science World website for more details and another link for tickets,

Join Science World, TRIUMF and guest speaker Dr Rocky Kolb on Wednesday, May 7 [2014], for another free Unveiling the Universe public lecture about the inner space/outer space connection that may hold the key to understanding the nature of dark matter, dark energy and the mysterious seeds of structure that grew to produce everything we see in the cosmos.

I notice Kolb is associated with the Fermi Lab, which coincidentally is where TRIUMF’s former director, Nigel Lockyer is currently located. You can find out more about Kolb on his personal webpage, where I found this description from his repertoire of talks,

Mysteries of the Dark Universe
Ninety-five percent of the universe is missing! Astronomical observations suggest that most of the mass of the universe is in a mysterious form called dark matter and most of the energy in the universe is in an even more mysterious form called dark energy. Unlocking the secrets of dark matter and dark energy will illuminate the nature of space and time and connect the quantum with the cosmos.

Perhaps this along with the next bit gives you a clearer idea of what Kolb will be discussing. He will also be speaking at TRIUMF, Canada’s national laboratory of particle and nuclear physics, from the events page,

Wed ,2014-05-07    14:00    Colloquium    Rocky Kolb, Fermilab     Auditorium    The Decade of the WIMP
Abstract:    The bulk of the matter in the present universe is dark. The most attractive possibility for the nature of the dark matter is a new species of elementary particle known as a WIMP (a Weakly Interacting Massive Particle). After a discussion of how a WIMP might fit into models of particle physics, I will review the current situation with respect to direct detection, indirect detection, and collider production of WIMPs. Rapid advances in the field should enable us to answer by the end of the decade whether our universe is dominated by WIMPs.

You may want to get your tickets soon as other lectures in the Unveiling the Universe series have gone quickly.

New director for TRIUMF, Canada’s national laboratory for particle and nuclear physics starts

Here’s the announcement, straight from the March 18, 2014 TRIUMF news release,

After a seven month, highly competitive, international search for TRIUMF’s next director, the laboratory’s Board of Management announced today that Dr. Jonathan Bagger, Krieger-Eisenhower Professor, Vice Provost, and former Interim Provost at the Johns Hopkins University, will join TRIUMF this summer as the laboratory’s next director.

TRIUMF is Canada’s national laboratory for particle and nuclear physics, focusing on probing the structure and origins of matter and advancing isotopes for science and medicine.  Located on the campus of the University of British Columbia, TRIUMF is owned and operated by a consortium of 18 leading Canadian universities and supported by the federal and provincial governments.

Bagger was attracted to TRIUMF because, “Its collaborative, interdisciplinary model represents the future for much of science.  TRIUMF helps Canada connect fundamental research to important societal goals, ranging from health and safety to education and innovation.”  Noting TRIUMF’s new strategic plan that recently secured five years of core funding from the Government of Canada, he added, “It is an exciting time to lead the
laboratory.”

Bagger brings extensive experience to the job.  Professor Paul Young, Chair of TRIUMF’s Board of Management and Vice-President of Research and Innovation at the University of Toronto, said, “Jon is an outstanding, internationally renowned physicist with a wealth of leadership experience and a track record of excellence.  He is a welcome addition to Canada and I am confident that under his tenure, TRIUMF will continue to flourish.”

Jim Hanlon, Interim CEO/Chief Administrator Officer of TRIUMF and President and CEO of Advanced Applied Physics Solutions Inc., welcomed the news.  He said, “The laboratory has been shaped and served greatly by its past directors.  Today the need continues for an extraordinary combination of vision, leadership, and excellence.  Jon will bring all of this and more to TRIUMF.  On behalf of the staff, we’re excited about moving forward with Jon
at the helm.”

Bagger expressed his enthusiasm in moving across the border to join TRIUMF as the next director. “TRIUMF is known internationally for its impressive capabilities in science and engineering, ranging from rare-isotope studies on its Vancouver campus to its essential contributions to the Higgs boson discovery at CERN.  All rest on the legendary dedication and commitment of TRIUMF’s researchers and staff.  I look forward to working with this
terrific team to advance innovation and discovery in Vancouver, in Canada, and on the international stage.”

Bagger will lead the laboratory for a six-year term beginning July 1 [2014].  He reports he is ready to go:  “I have installed a metric speedometer in my car, downloaded the Air Canada app, and cleansed my home of all Washington Capitals gear.”

Nice of Bagger to start his new job on Canada Day. From a symbolic perspective, it’s an interesting start date. As for his metric speedometer and Air Canada app, bravo! Perhaps though he might have wanted the last clause to feature the Vancouver Canucks, e.g., ‘and set aside money/have set aside space for Vancouver Canucks gear’. You can find out more about TRIUMF here.

Canadian Society for Chemistry honours Québec nanoscientist Federico Rosei

Dr. Federico Rosei’s name has graced this blog before, most recently in a June 15, 2010 posting about an organic nanoelectronics project. Late last week, Québec’s Institut national de la recherche scientifique (INRS) announced that Rosei will be honoured by the Canadian Society for Chemistry at  the 2014 Canadian Chemistry Conference (from the January 24, 2014 news release on EurekAlert),,

The Canadian Society for Chemistry (CSC) has bestowed its 2014 Award for Research Excellence in Materials Chemistry on Professor Federico Rosei, director of the INRS Énergie Matériaux Télécommunications research centre, in recognition of his exceptional contributions to the field. Professor Rosei will be honoured at the society’s annual conference, which will take place June 1 to 5, 2014, in Vancouver.

In conjunction with this honour, Federico Rosei has been invited to speak at this important scientific conference and to take part in a lecture tour of Canadian universities located outside major cities.

Professor Rosei has been widely honoured for his research on nanomaterial properties and their applications. He has received numerous awards and distinctions, including the 2013 Herzberg Medal from the Canadian Association of Physicists, the Brian Ives Lectureship Award from ASM Canada, the 2011 Rutherford Memorial Medal in Chemistry from the Royal Society of Canada, and the Alexander von Humboldt Foundation’s 2010 Friedrich Wilhelm Bessel Research Award. He is also a fellow of the American Association for the Advancement of Science; the Institute of Physics; the Royal Society of Chemistry; the Institute of Materials, Minerals and Mining; the Institute of Engineering and Technology; and the Institute of Nanotechnology in the U.K.; the Engineering Institute of Canada; and the Australian Institute of Physics. In addition, Professor Rosei is a Senior Member of the Institute of Electrical and Electronics Engineers (IEEE) and the Society for Photo-Image Engineers (SPIE), and a member of Sigma Xi (scientific research society) and the Global Young Academy.

Please join us in extending our congratulations to Professor Rosei!

###

The Canadian Society for Chemistry

The Canadian Society for Chemistry (CSC) is a not-for-profit professional association that unites chemistry students and professionals who work in industry, academia, and government. Recognized by the International Union of Pure and Applied Chemistry (IUPAC), the CSC awards annual prizes and scholarships in recognition of outstanding achievements in the chemical sciences.

About INRS

Institut national de recherche scientifique (INRS) is a graduate research and training university. As Canada’s leading university for research intensity in its class, INRS brings together some 150 professors and close to 700 students and postdoctoral fellows in its centres in Montreal, Quebec City, Laval, and Varennes. As active providers of fundamental research essential to the advancement of science in Quebec as well as internationally, INRS research teams also play a critical role in developing concrete solutions to problems that our society faces.

The French language version of the news release: de l’actualité le 23 janvier 2014, par Stéphanie Thibault (Note: Links have been removed from the excerpt),

Le professeur Federico Rosei du Centre Énergie Matériaux Télécommunications de l’INRS est récipiendaire du Prix d’excellence en chimie des matériaux 2014. La Société canadienne de chimie reconnaît ainsi sa contribution exceptionnelle dans ce domaine. Le professeur Rosei sera honoré lors du congrès annuel de la Société qui aura lieu du 1er au 5 juin 2014 à Vancouver.

À titre de lauréat, le professeur Rosei sera conférencier invité à cette importante rencontre scientifique et participera à une tournée de conférences qui l’amènera dans des universités canadiennes situées hors des grandes villes.

I have not found any specific details about Dr. Rosei’s upcoming chemistry lecture tour of universities.

The conference where Dr. Rosei will be honoured is the 97th annual Canadian Chemistry Conference and Exhibition. It is being hosted by Simon Fraser University (SFU), located in the Vancouver region. While the conference programme is not yet in place there’s a hint as to what will be offered in the conference chair’s Welcome message,

On behalf of the Organizing Committee, I am delighted to welcome all the delegates and their guests to Vancouver, British Columbia, for the 97th Canadian Chemistry Conference and Exhibition that will take place from June 1 to 5, 2014. This is Canada’s largest annual event devoted to the science and practice of chemistry, and it will give participants a platform to exchange ideas, discover novel opportunities, reacquaint with colleagues, meet new friends, and broaden their knowledge. The conference will held at the new Vancouver Convention Centre, which is a spectacular, green-designed facility on the beautiful waterfront in downtown Vancouver.

The theme of the CSC 2014 Conference is “Chemistry from Sea to Sky”; it will broadly cover all disciplines of chemistry from fundamental research to “blue sky” applications, highlight global chemical scientific interactions and collaborations, and feature the unique location, culture and beautiful geography (the Coastal Mountains along the ocean’s edge of Howe Sound) of British Columbia and Vancouver.

We are pleased to have Professor Shankar Balasubramanian (University of Cambridge, UK) and Professor Klaus Müllen (Max Planck Institute for Polymer Research, Mainz, Germany) as the plenary speakers. In addition to divisional symposia, the scientific program also includes several jointly organized international symposia, featuring Canada and each of China, Germany, Japan, Korea, Switzerland and the USA. This new type of symposium at the CSC aims to highlight research interests of Canadians in an international context. Interactions between chemists and TRIUMF (the world’s largest cyclotron, based in Vancouver) will also be highlighted via a special “Nuclear and Radiochemistry” Divisional Program.

All of the members of the local Organizing Committee from Simon Fraser University wish you a superb conference experience and a memorable stay in Vancouver. Welcome to Vancouver! Bienvenue à Vancouver!

Zuo-Guang Ye, Conference Chair
Department of Chemistry
Simon Fraser University
Burnaby, British Columbia

Conference abstracts are being accepted until February 17, 2014 (according to the conference home page). Dr. Shankar Balasubramanian was last mentioned (one of several authors of a paper) here in a July 22, 2013 posting titled: Combining bacteriorhodopsin with semiconducting nanoparticles to generate hydrogen.

Silence of the Labs (exposé) a Canadian Broadcasting Corporation (CBC) television event scheduled for January 10, 2014

I’ve perhaps overstated the case by calling the upcoming telecast ‘Silence of the Labs’ an event,. For many people in the Canadian science community, it will be an event but for most of the television audience it’s simply the first new episode of the Fifth Estate’s 2014 schedule. (For anyone unfamiliar with the Fifth Estate, it’s the Canadian Broadcasting Corporation’s [CBC] longest running, 39th season, and most prestigious investigative journalism television programme.)

Assuming there are some people who haven’t been following this story about the ‘silencing’ of Canada’s scientists or censorship as it has been called, here’s a précis (and if you’ve been following it more closely than I have and note any errors or have any additions, please do use the commenting option (Note: Due to spam issues, I moderate comments so it may take a few hours or more [I don't usually check the blog on the weekends]  before your comments appear.)

I think my earliest mention of the topic was in 2009 (Sept. 21, 2009; scroll down to the last paragraph). At this point, the Conservative government  had put a ‘muzzle’ on government scientists working for Environment Canada not allowing them to speak directly to media representatives about their work. All questions were to be directed to ministry communications officers. In fact, the muzzle was first discussed in a National Post Jan. 31, 200-8 article by Margaret Munro (which predates this blog’s existence by a few months). In a Sept. 16, 2013 posting, I featured the then recent muzzling of Natural Resources Canada, a story which was first covered by Margaret Munro. My understanding is that Health Canada had also been ‘muzzled’ but that was done earlier by the Liberal government when it was in power.

My colleague, David Bruggemen (Pasco Phronesis blog) disagrees with the contention by many in the Canadian science community that these ‘muzzles’ constitute a form of censorship. In addition to the postings he has made on his blog he also commented on my March 7, 2012 posting (I linked to one of David’s postings on the topic and included an excerpt from it) where I discussed my failure to get answers to questions from an institution located on the University of British Columbia lands and linked it to the ‘muzzle’. In that context,, I mused about censorship.

Since 2012 the focus seems to have shifted from media representatives being able to get direct and uninhibited access to scientists to the public’s right to know and attempts to ‘shut down’ scientific inquiry. In July 2012, there was a rally in Ottawa called Death of Evidence (discussed in both my July 10, 2012 posting and my July 13, 2012 posting followed by a 2013 cross Canada event, Stand up for Science described in my Oct. 4, 2013 posting. As I noted in that posting, most of the science being ‘censored’ or ‘attacked’ is environmental. Institutions such as the Perimeter Institute (theoretical physics)  in Ontario and TRIUMF, Canada’s National Laboratory for Particle and Nuclear Physics in British Columbia have done very well under the Conservative government.

with all that, here’s a preview (51 seconds) of the Silence of the Labs,

You can find out more about the episode here and, if you should miss the telecast, you’ll probably be able to watch later on the Fifth Estate’s CBC  Player webpage. As for the ‘Silence of the Labs” (hat off for the pun), I believe it will be broadcast at 9 pm regardless of timezone on the local CBC channel across most of the country; I assume that as usual Newfoundland will enjoy the telecast at 9:30 pm.

*Four Vancouver (Canada) science events: Policy Making and Science; Solving a global medical crisis with a particle accelerator; and Marc Garneau asks, Should Canada be in space?; light to quantum materials

It’s going to be busy in Vancouver (Canada) next week, if you plan your life around the city’s science events.

The first event, “The Art of Policy Making: What’s Science Got to Do With It?” is being held by the Canadian Association for the Advancement of Science. It will be held at lunchtime on Tuesday, November 26, 2013 at Simon Fraser University’s Harbour Centre campus in downtown Vancouver.

The Art of Policy Making:

What’s Science Got to Do With It?

Speaker: Andrew Petter, President of Simon Fraser University

Panelists: Adam Walters-Navigate Surgical Company, Vancouver, B.C. and David S. Fushtey, Senior Fellow,, Centre for Corporate Governance and Risk Management, SFU Beedie Faculty of Business, and Fellow, SFU Centre for Dialogue

Moderator: Bill Good, CKNW Radio, Vancouver, B.C.

Co-Chairs: Martin Zuckermann, D.Phil. (Oxon), FRSC, Emeritus Professor of Physics, McGill University

Olga A. Barrat, Ph.D., Research Scientist

Date: November 26, 2013

Location:
Simon Fraser University
Harbour Centre / Segal Centre
515 West Hastings, Vancouver
Registration: 11:30 a.m.
Presentation: 12:10 p.m.
Discussion: 12:50 – 1:45 p.m.

Pre-register via email at: [email protected]
Or by post to CAAS at the address or fax number noted below
Tickets: $35.00 (payable at the door by cash or cheque)
Information: [email protected]

For that price I hope they are including lunch. I did not realize we had a Canadian Association for the Advancement of Science (established in 1999) or that it was located in North Vancouver,

CANADIAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE
P.O. Box 75513, 3034 Edgemont Blvd., North Vancouver, B.C., Canada V7R 4X1 / Fax: 604-926-5806
www.caas-acascience.org

The next day, you can trot off to: ‘Medicine Accelerated: Canada’s role in the Medical Isotope Revolution’ (part of the Unveiling the Universe Lecture Series) will be held on Wednesday, 27 November 2013 from 7:00 PM to 9:00 PM (PST) at Vancouver’s Science World., From the Nov. 15, 2013 TRIUMF;Canada’s National Laboratory for Particle and Nuclear Physics news release,

Medicine Accelerated: Canada’s role in the Medical Isotope Revolution

Join Science World and TRIUMF in welcoming Dr. Paul Schaffer for a free public lecture at the TELUS World of Science Wednesday November 27, 2013.  As part of the “Unveiling the Universe” lecture series presented by TRIUMF and Science World, Dr. Schaffer will be speaking about recent advances in radiopharmaceuticals and and their role in the diagnosis, treatment, and management of diseases such as cancer and Alzheimer’s. he also will be highlighting Canada’s leadership role in developing cyclotron particle-accelerator technology to create medical isotopes.  This lecture is offered in cooperation with ARPICO, the Society of Italian Researchers and Professionals in Western Canada. (www.arpico.ca).

Tickets are free but registration is required.

Visit http://medicine-accelerated.eventbrite.ca  to reserve your seat.

Doors open at 6pm with the lecture starting at 7pm.   There will be a Q&A session to follow.

A live webcast of the lecture will be available online (requires Silverlight plugin). Visit registration site for link.

About Paul Schaffer

Paul Schaffer is the Division Head of the Nuclear Medicine program at TRIUMF, Canada’s national lab for particle and nuclear physics in Vancouver, BC. He is responsible for maintaining TRIUMF’s medical isotope and radiotracer production programs in support of neurological and oncological research. He was recently recognized as one of British Columbia’s Top Forty under 40 by Business in Vancouver magazine

About Science World

Science World British Columbia is a not-for-profit organization that engages British Columbians in science and inspires future science and technology leadership throughout our province.

About TRIUMF

TRIUMF is Canada’s national laboratory for particle and nuclear physics. It is owned and operated by a consortium of Canadian universities and is funded by a contribution through the National Research Council of Canada. The Province of British Columbia provides capital funding for the construction of buildings for the TRIUMF Laboratory.

There are some 23 General Admission tickets still available as of November 20, 2013 (9:15 am PST). This talk is likely to touch on TRIUMF’s recently ‘unveiled’ medical cyclotron (from my June 9, 2013 posting),

Today, Sunday, June 9, 2013, TRIUMF, Canada’s national laboratory for particle and nuclear physics, and its partners announced that they have devised a technique for producing medical isotopes that is not dependent on materials from nuclear reactors. From the June 9, 2013 TRIUMF news release,

With Canadian-developed tools and technology, a national team led by TRIUMF has reached a crucial milestone at the BC Cancer Agency in developing and deploying alternatives for supplying key medical isotopes. The team used a medical cyclotron that was designed and manufactured by Advanced Cyclotron Systems, Inc. (ACSI) of Richmond, BC, and successfully achieved large-scale production of technetium-99m (Tc-99m), sufficient for a metropolitan area.

The team announced the successful ramp-up of its technology to regularly produce enough of the critical Tc-99m isotope to supply an urban area the size of Vancouver. This achievement eliminates the need for nuclear reactors to produce isotopes, especially those that use weaponsgrade uranium, which has been the traditional approach.

ETA Nov. 25, 2013: There’s a Nov. 22, 2013 news item (Medical isotope supply interrupted across Canada; Delivery of one isotope to hospitals down to less than 50 per cent of normal) on CBC (Canadian Broadcasting Corporation) News online about the latest shortage of medical isotopes.

The third event is being hosted by Canadian Member of Parliament,(Liberal) Joyce Murray (Vancouver Quadra) on Friday, November 29, 2013 at Enigma Restaurant on W. 10th Avenue near the University of British Columbia. From the November 15, 2013, invitation,

Please join Member of Parliament Joyce Murray at her Friday November 29th MP Breakfast Connections discussion with guest speaker Marc Garneau, MP: “Does Canada need a Space Program?”

 Be part of the conversation with Canada’s first Astronaut and former President of Canada’s National Space Agency, Marc Garneau.  Canada’s Space Agency began in 1990, with a mission to lead the development and application of space knowledge for the benefit of Canadians and humanity.  Canadians have made significant contributions to space travel with the robotic Canadarm, developed in part here in British Columbia, by MacDonald Dettweiler, and we were all enthralled last year when Canadian Chris Hadfield was commander of the International Space Station and shared his experiences from space.  Is there a future for Canada’s  Space Agency?  Let’s ask Marc!

Details:

Friday, November 29, 2013

7:30 – Registration + Buffet Breakfast

7:50 – 8:45 Speaker + Q and A

Enigma Restaurant – 4397 W. 10th Ave. (Off Trimble) (map)

The cost of the breakfast is $20 / $10 for students.

(Cash only at the door)

Please RSVP to [email protected] or by calling 604-664-9220.

Interestingly, Canadian astronaut Chris Hadfleld has been in Vancouver giving interviews (Nov. 18, 2013 on The Rush television programme), as he’s been promoting his new book, An Astronaut’s Guide to Life on Earth. You can find out more about the book at http://chrishadfield.ca/

Btw, I have been to Joyce’s breakfasts before and they serve a good breakfast at Enigma.

*As of Nov. 20, 2013, 2:30 pm PDT: I’m adding one more event: Vancouver’s Café Scientifique is being held in the back room of the The Railway Club (2nd floor of 579 Dunsmuir St. [at Seymour St.], Vancouver, Canada), on Tuesday, November 26,  2013 at 7:30 pm. Here’s the talk description (from the Nov. 20,, 2013 announcement,

Our speaker for the evening will be Dr. Andrea Damascelli.

From Light Quanta to Quantum Materials

he photoelectric effect – the ejection of electrons from a solid consequent to the absorption of light – was discovered by Hertz in 1887 and explained by Einstein in 1905 on the basis of the revolutionary hypothesis of Light Quanta, or photons. This intuition, which gave Einstein the Nobel Prize in Physics in 1921, marked the beginning of quantum physics and also of photoelectric spectroscopy, one of the most active fields in modern science and technology. Owing to recent technical progress and in particular to the development of third generation synchrotron sources – particle accelerators in which electrons traveling at nearly the speed of light generate the most brilliant light available to scientists – the last decade witnessed a renaissance in this technique and its applications. These have now become the primary tools in the study of emerging Quantum Materials, systems which manifest a wide range of astonishing electronic and magnetic phenomena and with the potential to revolutionize consumer electronics, telecommunications, next-generation computing, alternative energy, and medicine.

You can find Dr. Damascelli’s profile page here on the University of British Columbia website.

TRIUMF announces both an interim director and an unusual job sharing plan with Japan

A July 17, 2013 TRIUMF news release announces a new interim structure (CEO? and name change?) and an international search for a permanent replacement while they wish current director Nigel Lockyer well as he dances out the door to his new job as director of the US Fermi National Accelerator Laboratory in Chicago, Illinois,

TRIUMF’s Board of Management today announced plans for interim leadership of the laboratory.  Present director Nigel S. Lockyer will be leaving TRIUMF and headed to the U.S. Fermi National Accelerator Laboratory as its new director effective September 3, 2013.  Interim leadership will be provided by the Board and a team of current senior staff.

In its discussions, the Board reviewed the following considerations:

+ The laboratory’s near-term activities and plans are well-defined and
publicly declared in its Five-Year Plan 2010-2015;
+ Effective stewardship of the laboratory in this interim period requires
familiarity and experience with TRIUMF;
+ The senior management team of the laboratory is successful and efficient;
and
+ The Board of Management, representing the university owners of TRIUMF, is
ultimately responsible for the laboratory and its operations and the
fulfillment of the laboratory’s mission.

To achieve these objectives, an interim-leadership structure composed of a management team, direct participation by members of the Board, and a new President and CEO of TRIUMF Accelerators, Inc. will be implemented on August 1, 2013 (thereby providing one-month overlap with the present Laboratory Director).

The Board of Management will exercise oversight and control of TRIUMF through weekly meetings between laboratory management and the Chair of the Finance Committee of the Board and monthly meetings between laboratory management and the Chair of the Board.

The laboratory will manage day-to-day operations using a team of existing senior staff.  The team will consist of three elements:

1. Scientific and Engineering Leadership Team (including the Heads of the Science, Engineering, Nuclear Medicine, and Accelerator Divisions);
2. Administrative Leadership Team (including the Chief Financial Officer; the Head of the Business and Administration Division; the Manager, Environment, Health and Safety; and the Head of Strategic Planning and Communication); and
3. An Interim Chief Executive Officer / Chief Administrative Officer (CEO/CAO) who will have signing authority for TRIUMF and will be responsible for the smooth operation and performance of the teams.  This role will be filled by Jim Hanlon who will be accountable to the Board on a day-to-day
basis for the laboratory. Jim is currently Head of the Business & Administration Division and Secretary to the TRIUMF Board of Management.

The new interim President and CEO of TRIUMF Accelerators, Inc. will be Jim Hanlon.  [emphasis mine] Other officers remain as they are.  The interim and transitional arrangement will be operative for six months, or extended following review, until the next director is appointed.

With regard to selecting a new director of the laboratory, the chair of the Search Committee has been identified and the full committee is being convened.  The international search will be launched by August 1.

This is fascinating and it’s nice to have a name for the new ‘head poobah’  although they’ve decided to restructure in a rather **unexpected and dramatic fashion with the decision to appoint a temporary Chief Executive Officer (CEO) and President, not a director as was Lockyer. Plus they seem to have changed the organization’s name in **the news release, TRIUMF Accelerators, Inc., as opposed to TRIUMF; Canada’s National Laboratory for Particle and Nuclear Physics. Oddly, the name change is not reflected on the website as of July 18, 2013 11:45 PDT nor is it officially announced in the news release.

I did speculate as to some of the issues that might arise when a leader departs in a June 21, 2013 posting where I used Tim Meyer (Head, Strategic Planning & Communications) as an example and described some of the issues that might arise regardless of whom is chosen from an internal pool for an interim position but I never anticipated this dramatic shift to a structure that mimics a corporation rather than a scientific enterprise. (It seems to me their appointee, Jim Hanlon, heads the Business & Administration Division and is Secretary to the Board of Management is in the unenviable position of not having much authority, other than signing authority,  in a situation where he carries a lot of responsibility.)

Assuming that this is a permanent change in structure, they will be searching for a president and CEO not a director which along with the name change suggests that the emphasis will be on business qualifications as much as, or perhaps more so, than on research qualifications. *Coincidentally or not, the new, as of July 15, 2013, Minister of State for Science and Technology, Gary Rickford has an MBA (Masters of Business Administration) in addition to his nursing qualifications and legal degree. I covered this latest cabinet shuffle and the change to the junior ministry (Sci & Tech) and its parent ministry, Industry Canada, in my July 17, 2012 posting.)

Given the Canadian federal government’s appetite for commodifying scientific research and imposing business models on the research community, this seems like a smart and strategic move on TRIUMF’s part. (For an example of the Harper government’s appetite, I wrote about Canada’s National Research Council and its change to a business-oriented focus in my May 13, 2012 posting and May 22, 2013 posting.)

I note this change to a corporate name and structure comes from within the science community and is not being imposed by the government. It seems that as scientists see how the wind is blowing they will turn direction. Of course, that’s pretty standard behaviour in any sector. What makes this situation at TRIUMF particularly interesting is the implication for the future as young scientists are likely to increasingly adopt business attitudes to their work. Since business is primarily about making money and the last time we encouraged youth to pursue money at all costs we ended up with at least two economic meltdowns and a generation of investment bankers, we are likely to run short (again) of critically needed skills in areas that **don’t promise ‘a fast buck’.

Finally, here’s my bit about a unique job sharing plan between TRIUMF (issued prior to the name change?) and a laboratory in Japan. From a July 11, 2013 TRIUMF news release,

In an unusual alliance between TRIUMF, Canada’s national laboratory for nuclear and particle physics, and the Kavli Institute for the Physics and Mathematics of the Universe (Kavli IPMU) in Japan, a long-term joint research position has been created in order to recruit, develop, and
support a world-leading scientist in two countries.  The catch?  After working for the first four years with 75% of his time in Japan and 25% in Canada, the candidate will choose which laboratory’s long-term job offer to accept. American physicist Dr. Mark Hartz has been selected for this
high-stakes competition and in five years will be choosing his long-term home in Tokyo or Vancouver.

From either side of the Pacific Ocean, there will continue to be a great demand for Hartz. He has been appointed as assistant professor and is expected to carry out the full range of duties of a grant tenure track research scientist at both Kavli IPMU and TRIUMF. Additionally, he will serve on internal committees and represent both institutes at the national and international level. His cross-cultural and cross-laboratory experiences will be a great benefit for both Kavli IPMU and TRIUMF.

Dr. Nigel S. Lockyer, director of TRIUMF, acknowledged the rarity and significance of Hartz’s role. Lockyer said, “We need more competitive, cross-border positions like this to enrich and strengthen top talent. I’m delighted that Japan agrees that Hartz is worth fighting for, and yet I’m confident that in the long term Canada is the right place for him and his world-class research ambitions.”

Dr. Hitoshi Murayama, director of Kavli IPMU, said, “Mark is a tremendous addition to our team and will help expand our institutional role in the Japanese flagship T2K neutrino experiment. Once he comes to Kavli IPMU and sees our fantastic environment with interdisciplinary interactions with
astronomers and mathematicians, I have no doubt that he will settle down here.  We already have a great track record of keeping our non-Japanese scientists happy and productive.”

In recent years, Hartz experienced the enormous benefits of global collaboration through research at the Tokai to Kamioka (T2K) neutrino experiment-an international investigation into the behaviour of neutrinos as they travel from one location to another, where he led national efforts to develop beamline monitors and analysis specific to the experiment. With his advanced technical and engineering background, Hartz is an ideal candidate for this cross-laboratory role. He will continue to focus his tenure on the T2K collaboration and is expected to build a strong T2K experimental group at Kavli IPMU.

“The T2K experiment is a textbook example of scientists working across borders to drive new discoveries and pursue the best science,” said Hartz. “This joint position is a brilliant opportunity to work with research communities and give momentum to those interactions.  Although national
borders are invisible to the scientist in me, I am curious to see where I’ll end up in five years!”

As a post-doctoral fellow at both York University and the University of Toronto, Hartz gained extensive experience with the T2K Optical Transition detector and led both the beam analysis and Near Detector to Far Detector Extrapolation analysis groups. He completed detailed predictions of neutrino beam properties prior to the neutrino changing its form in a phenomenon called “neutrino oscillation”. Additionally, Hartz developed sophisticated analysis tools to constrain the neutrino beam flux-an important element for analyzing the oscillations of neutrinos.

Other than being confused as to whether Hartz is making his choice of laboratory and country after four years or five, I do find this to be an innovative approach to recruiting researchers and I see advantages for both the researchers and the labs. I am curious as to why it’s a 75%/25% split in favour of the Kavli Institute (PMU) in Japan. Does it have something to do with initiating this unique opportunity? O perhaps since the researcher is Canadian and more time is needed in Japan so he might acclimate and make a more informed decision?

Regardless, bravo to both the Kavli Institute (PMU) and TRIUMF for taking a bold approach to attracting exciting researchers to their respective institutions.

* Opening paranthesis removed on July 19, 2013.

** ‘and’ removed, ‘the’ added’, and ‘didn’t’ changed to ‘don’t’ on Aug. 1, 2013

Mysteries of the quantum universe; a July 12, 2013 public talk at Vancouver’s (Canada) Science World

Happy Canada Day! I think today’s only posting will be this one about an upcoming public event in Vancouver, from the June 28, 2013 announcement from TRIUMF; Canada’s national laboratory for particle and nuclear physics,

“Mysteries of the Quantum Universe”
Public lecture Friday July 12, 7pm, TELUS World of Science
 
(Vancouver, BC)  Join Science World and TRIUMF in welcoming Dr Hitoshi Murayama for a free physics lecture at TELUS World of Science on Friday, July 12. Dr Murayama will be speaking about neutrinos, anti-matter and dark matter as part of the “Unveiling the Universe” lecture series presented by TRIUMF and Science World.
Dr Murayama is well-known for his enthusiastic lectures for student and general audience.
About Hitoshi Murayama:
Dr Murayama lives to solve nature’s elemental puzzles like eccentric particles, dark matter and why our universe is expanding so swiftly. He received his PhD in theoretical physics from University of Tokyo in 1991. Dr Murayama became a senior staff member at Lawrence Berkeley National Laboratory and the MacAdams Professor of Physics at the University of California, Berkeley. In 2007, Dr Murayama was named the founding director of the University of Tokyo’s Kavli Institute for the Physics and Mathematics of the Universe. The institute’s goal is to use the synergistic perspectives of mathematics, astronomy and theoretical and experimental physics to reveal how the cosmos was formed, how it runs and why we exist.
Doors open at 6:15pm and the presentation starts at 7pm. Q&A session to follow. Tickets are free, but online registration is required. See:
 
Note that a livestream of the lecture (Silverlight plugin required) will be available online for any who are interested and are unable to make it to the event in person. (See registration site for lifestream link)

As far as I can tell, there are still seats as of July 1, 2013 9 am PDT. Oddly, this event is not mentioned on the Science World homepage or elsewhere nor does it seem to be mentioned on the TRIUMF website..

TRIUMF looks for new Director as Nigel S. Lockyer exits for the Fermilab (US)

The circumstances around Nigel S. Lockyer’s departure as Director of Canada’s National Laboratory for Particle and Nuclear Physics, TRIUMF,  are very interesting. Just weeks ago, TRIUMF announced a major innovation for producing medical isotopes (my June 9, 2013 posting), which should have an enormous impact on cities around the world and their access to medical isotopes. (Briefly, cities with cyclotrons could produce, using the technology developed by TRIUMF,  their own medical isotopes without using material from nuclear reactors.)

Also in the recent past, Canada’s much storied McGill University joined the TRIUMF consortium (I’m surprized it took this long), from the May 10, 2013 news release,

At its recent Board of Management meeting, TRIUMF approved McGill University as an associate member of the consortium of universities that owns and operates Canada’s national laboratory for particle and nuclear physics. McGill joins 17 other Canadian universities in leading TRIUMF.

Paul Young, Chair of the Board and Vice President for Research at the University of Toronto, said, “The addition of McGill to the TRIUMF family is a great step forward. McGill brings world-class scientists and students to TRIUMF and TRIUMF brings world-leading research tools and partnerships to McGill.”

The university’s closer association with TRIUMF will allow it to participate in discussions about setting the direction of the laboratory as well provide enhanced partnerships for new research infrastructure that strengthens efforts on McGill’s campuses. Dr. Rose Goldstein, McGill Vice-Principal (Research and International Relations), said, “We are delighted to formalize our long-standing involvement in TRIUMF. It is an important bridge to international research opportunities at CERN and elsewhere. Associate membership in TRIUMF will also help McGill advance its Strategic Research Plan, especially in the priority area of exploring the natural environment, space, and the universe.”

McGill University has been involved in TRIUMF-led activities for several decades, most notably as part of the Higgs-hunting efforts at CERN. TRIUMF constructed parts of the Large Hadron Collider that ultimately produced Higgs bosons. The co-discovery was made by the ATLAS experiment for which TRIUMF led Canadian construction of several major components, and McGill played a key role in the development of the experiment’s trigger system. McGill and TRIUMF have also worked together on particle-physics projects in Japan and the U.S.

Professor Charles Gale, chair of the Department of Physics, played a key role in formalizing the relationship between TRIUMF and McGill. He said, “Our department is one of the top in North America in research, teaching, and service. Undoubtedly our work with TRIUMF has helped contribute to that and I expect both institutions to blossom even further.” Professor of physics and Canadian Research Chair in Particle Physics Brigitte Vachon added, “TRIUMF provides key resources to my students and me that make our research at CERN possible; the discovery of the Higgs boson is a perfect example of what such collaboration can achieve.”

Nigel S. Lockyer, director of TRIUMF, commented, “The addition of McGill to the TRIUMF team is welcome and long overdue. We have been working together for decades in subatomic physics and this acknowledgment of the partnership enhances both institutions and builds stronger ties in areas such as materials science and nuclear medicine.”

A scant month after McGill joins the consortium and weeks after a major announcement about medical isotopes, Lockyer announces his departure for the Fermilabs in the US, from the May 20, 2013 TRIUMF news release,

In his capacity as Chairman of the Board of Directors of Fermi Research Alliance, LLC, University of Chicago President Robert J. Zimmer today announced that TRIUMF’s director Nigel S. Lockyer has been selected to become the next director of the U.S. Department of Energy’s Fermi National Accelerator Laboratory, located outside Chicago.  Lockyer is expected to complete his work at TRIUMF this summer and begin at Fermilab in the autumn.

Paul Young, Chair of TRIUMF’s Board of Management and Vice President of Research and Innovation at the University of Toronto said, “Nigel was selected from a truly outstanding set of international candidates for this challenging and important position.  Although it will be a short-term loss, this development is a clear recognition of Nigel’s vision and passion for science and the international leadership taken by TRIUMF and Canada in subatomic physics.  On behalf of the entire TRIUMF Board, we wish Nigel, TRIUMF, and Fermilab every success in the future.”

Lockyer set TRIUMF upon a new course when he arrived six years ago, focusing the team on “Advancing isotopes for science and medicine.”  Based on TRIUMF’s existing infrastructure and talent, this initiative ranged from expanding the nuclear-medicine program so that it is now playing a leading role in resolving the medical-isotope crisis to the formulation and funding of a new flagship facility called ARIEL that will double TRIUMF’s capabilities for producing exotic isotopes used in science and for developing tomorrow’s medical isotopes.  At the heart of ARIEL is a next-generation electron accelerator using modern superconducting radio-frequency technology.

Commenting on Nigel’s leadership of TRIUMF, Paul Young added, “One look at TRIUMF’s current trajectory and you can see that this is a man of great ambition and talent.  Working with the Board and a great team at the lab, he propelled TRIUMF to new heights.  We have all been fortunate at TRIUMF to have Nigel as a colleague and leader.”

Reflecting on his time at TRIUMF and the upcoming transition to Fermilab, Nigel Lockyer said, “Knowing that TRIUMF is in good hands with a superb leadership team and seeing its growing string of accomplishments has helped make this decision a tiny bit easier.  The laboratory’s future is secure and TRIUMF knows exactly what it is doing.  I am proud to have contributed to TRIUMF’s successes and it is my hope to ignite the same energy and enthusiasm in the U.S. by heading the team at Fermilab.”  He added, “I also expect to foster a new level of partnership between the U.S. and Canada in these key areas of science and technology.”

“Nigel has had a profound impact on TRIUMF,” said David B. MacFarlane, chair of the National Research Council’s Advisory Committee on TRIUMF and Associate Laboratory Director at the U.S. SLAC National Accelerator Laboratory.  “He articulated an ambitious new vision for the laboratory and energetically set it upon a path toward an exciting world-class program in rare-isotope beams and subatomic-physics research.  When ARIEL comes online, the lab will be fulfilling the vision that Nigel and his team boldly initiated.”  David MacFarlane added, “The TRIUMF community will certainly miss his warmth, his insatiable scientific curiosity, his creativity, and his faith in the laboratory and its entire staff.  However, I fully expect these same characteristics will serve Nigel well in his new leadership role as Fermilab director.”

As per standard practice, the TRIUMF Board of Management will announce plans and timelines for the international search process and interim leadership within the next few weeks.

Before speculating on the search process and interim leadership appointment, I have a comment of sorts about the Fermilab, which was last mentioned here in my Feb. 1, 2012 posting where I excerpted this interesting comment from a news release,

From the Feb. 1, 2012 news release on EurekAlert,

In this month’s Physics World, reviews and careers editor, Margaret Harris, visits the Fermi National Accelerator Laboratory (Fermilab) to explore what future projects are in the pipeline now that the Tevatron particle accelerator has closed for good.

After 28 years of ground-breaking discoveries, the Tevatron accelerator has finally surrendered to the mighty Large Hadron Collider (LHC) at CERN [European Laboratory for Particle Physics], placing Fermilab, in some people’s mind, on the brink of disappearing into obscurity. [emphasis mine]

It seems the Fermilab is in eclipse and Lockyer is going there to engineer a turnaround. It makes one wonder what the conditions were when he arrived at TRIUMF six years ago (2006?). Leading on from that thought, the forthcoming decisions as to whom will be the interim Director and/or the next Director should be intriguing.

Usually an interim position is filled by a current staff member, which can lead to some fraught moments amongst internal competitors.  That action, however fascinating, does not tend to become fodder for public consumption.

Frankly, I’m more interested in the board’s perspective. What happens if they pick an internal candidate while they prepare for the next stage when they’re conducting their international search? Based on absolutely no inside information whatsoever, I’m guessing that Tim Meyer, Head, Strategic Planning & Communications for TRIUMF, would be a viable internal candidate for interim director.

From a purely speculative position, let’s assume he makes a successful play to become the interim Director. At this point, the board will have to consider what direction is the right one for TRIUMF while weighing up the various candidates for the permanent position.  Assuming the interim Director is ambitious and wants to become the permanent Director, the dynamics could get very interesting indeed.

From the board’s perspective, you want the best candidate and you want to keep your staff. In Canada, there’s one TRIUMF; there are no other comparable institutions in the country.  Should an internal candidate such as Meyer get the interim position but not the permanent one (assuming he’d want to be the permanent Director) he would have very few options in Canada.

Based on this speculation, I can safety predict some very interesting times ahead for TRIUMF and its board. In the meantime, I wish Lockyer all the best as he moves back to the US to lead the Fermilab.

Dazzling possibilities for creating medical isotopes

The possibility medical isotopes could be produced with cyclotrons  is dazzling, especially in light of the reports a few years ago when it was discovered that the Chalk River facility (Ontario, Canada), the source for one 1/3 of the world’s medical isotopes, was badly deteriorated (my July 2, 2010 posting). Today, Sunday, June 9, 2013, TRIUMF, Canada’s national laboratory for particle and nuclear physics, and its partners announced that they have devised a technique for producing medical isotopes that is not dependent on materials from nuclear reactors. From the June 9, 2013 TRIUMF news release,

With Canadian-developed tools and technology, a national team led by TRIUMF has reached a crucial milestone at the BC Cancer Agency in developing and deploying alternatives for supplying key medical isotopes. The team used a medical cyclotron that was designed and manufactured by Advanced Cyclotron Systems, Inc. (ACSI) of Richmond, BC, and successfully achieved large-scale production of technetium-99m (Tc-99m), sufficient for a metropolitan area.

The team announced the successful ramp-up of its technology to regularly produce enough of the critical Tc-99m isotope to supply an urban area the size of Vancouver. This achievement eliminates the need for nuclear reactors to produce isotopes, especially those that use weaponsgrade uranium, which has been the traditional approach.

Of course, the metropolitan area will need its own cyclotron and the technology has yet to be proven in an industrial-grade production facility. The news release goes on to explain the situation with medical isotopes,

Each year, tens of millions of medical procedures are conducted around the world with Tc-99m, an isotope used in radiopharmaceuticals for imaging disease in the heart, bones, and elsewhere in the body. Two aging nuclear reactors produce about three quarters of the global supply; one of them is the National Research Universal (NRU) reactor in Chalk River, Ontario. In the past few years, both reactors have suffered maintenance and repair outages, threatening the global supply of medical isotopes.

Here are some more technical details about the project,

“The approach taken by our consortium has established the feasibility of producing appreciable quantities of Tc-99m on Canada’s existing cyclotron network. These same machines are also producing additional isotopes used in a growing number of alternative imaging procedures. The net effect is that Canada will remain on the forefront of medical-isotope technology for the
foreseeable future,” said John Valliant, Scientific Director and CEO of the CPDC in Hamilton.

In February 2012, the TRIUMF-led team demonstrated that the production of Tc-99m was possible on existing medical cyclotrons based in BC and Ontario. After a year of scaling up performance and making engineering improvements to target fabrication, control, and purification procedures, the team has achieved its next milestone: the production of enough Tc-99m in a six hour overnight shift at the BC Cancer Agency Vancouver Centre to supply the demands of a metropolitan area (roughly equivalent to 10 Curies). The next milestones for TRIUMF and its partners include engineering optimization and regulatory approval.

As for the future (from the news releases),

Commenting on the path forward, TRIUMF’s director Nigel Lockyer said, “Having cleared this technical hurdle, we are well on our way to assembling the right team to make a competitive proposal to join the BC supply chain for medical isotopes such as technetium-99m. I look forward to working with existing and new partners, including ACSI, in making this possible.”

For those who are curious about the partners,

About TRIUMF

TRIUMF is Canada’s national laboratory for particle and nuclear physics. Together with its partner AAPS, Inc., TRIUMF also seeks to commercialize its technologies for the benefit of all Canadians. Located on the south campus of the University of British Columbia, TRIUMF receives operating support from the Government of Canada through a contribution agreement via National Research Council Canada; the Government of British Columbia provides capital for new buildings. TRIUMF is owned and operated as a joint venture by a consortium of the following Canadian universities: University of Alberta, University of British Columbia, University of Calgary, Carleton University, University of Guelph, University of Manitoba, McGill University, McMaster University, Université de Montréal, University of Northern British Columbia, Queen’s University, University of Regina, Saint Mary’s University, Simon Fraser University, University of Toronto, University of Victoria, University of Winnipeg, and York University. For more information, please visit us at http://www.triumf.ca.

About ACSI

In 2003, Ebco Industries—using technology licensed from world-renowned subatomic-physics research centre, TRIUMF—founded ACSI with a goal to revolutionize cyclotron design. Since then, ACSI has specialized in producing advanced cyclotrons that can meet the world’s growing isotope needs. As part of the Government of Canada’s Isotope Technology Acceleration Program (ITAP), ACSI is a member of a consortium funded alongside the TRIUMF team to develop viable alternatives to nuclear reactor-produced medical isotopes. For more information, please visit us at http://www.advancedcyclotron.com.

About the BC Cancer Agency

The BC Cancer Agency, an agency of the Provincial Health Services Authority, is committed to reducing the incidence of cancer, reducing the mortality from cancer, and improving the quality of life of those living with cancer. It provides a comprehensive cancer control program for the people of British Columbia by working with community partners to deliver a range of oncology services, including prevention, early detection, diagnosis and treatment, research, education, supportive care, rehabilitation and palliative care. The BC Cancer Foundation raises funds to support research and enhancements to patient care at the BC Cancer Agency.

About the Centre for Probe Development and Commercialization

The Centre for Probe Development and Commercialization (CPDC) discovers, develops and distributes molecular imaging probes for the early diagnosis of diseases and to assess the effectiveness of treatments. An important part of Ontario’s health system, CPDC provides a reliable, daily supply of imaging probes to hospitals across the province. CPDC also works collaboratively with industry and academic partners, offering the research, manufacturing and regulatory expertise needed to move innovative probe technology and new therapeutic drugs from R&D labs to clinical use. CPDC, located on the McMaster University Campus, is a Centre of Excellence for Commercialization and Research, part of the Networks of Centres of Excellence Program. It is supported by the Ontario Institute for Cancer Research, GE Healthcare, Cancer
Care Ontario, and McMaster University.

About Lawson Health Research Institute

Lawson Health Research Institute, located in London, Ontario, is one of Canada’s largest and most respected hospital-based research institutes. As the research arm of London Health Sciences Centre and St. Joseph’s Health Care, London, and working in partnership with The University of Western Ontario, Lawson is committed to furthering scientific knowledge to advance health care around the world. Its state-of-the-art, 6,000 sq. ft. Cyclotron & PET Radiochemistry Facility opened on March 31, 2010 and includes a GE PETtrace 880 cyclotron with proton and deuteron acceleration capability, class 100 shielded hot cells, and automated chemistry units for producing F-18 and C-11 radiopharmaceuticals – all to GMP specifications.

Exciting stuff!

Vancouver’s (Canada) Café Scientifique; an origins story on May 28, 2013

Returning to  the back room at The Railway Club (2nd floor of 579 Dunsmuir St. [at Seymour St.], Vancouver, Canada), the next Café Scientifique Vancouver talk will be given by Lars Martin on Tuesday, May 28,  2013 at 7:30 pm. Here’s the talk description, from the announcement,

Nuclear Astrophysics at TRIUMF

Nuclear Astrophysics is the field of science that tries to explain the natural origin of all chemical elements. [emphasis mine] Scenarios that are studied in this field include the Big Bang, the life cycle of a regular star like our sun and cataclysmic events like supernovae. One key ingredient for this endeavour is the experimental study of nuclear reactions in accelerator labs like TRIUMF.

In his presentation Lars Martin will give an introduction into the field of nuclear astrophysics and describe some of the experiments he was involved with as a PhD student at TRIUMF.

That’s all I’ve got.